Kazia Therapeutics KZIA
NASDAQ KZIA
$6.62 -0.33 (-4.75%)
At close: Nov 13, 2026 · 4:00 PM EST

Kazia Therapeutics (KZIA) Debt Ratio (2013 - 2025)

Updated

Kazia Therapeutics' Debt Ratio came in at 0.20 for fiscal Q2 2026 (quarter ended Dec 31, 2025).

Analysis

Kazia Therapeutics (KZIA) Debt Ratio (2013 - 2025) Analysis & Trends

For FY2025 (ended Jun 30, 2025), Kazia Therapeutics' Debt Ratio was 0.59.

  • Going back by fiscal year, Debt Ratio was 0.15 in FY2024 (-53.9%), 0.32 in FY2023 and 0.02 in FY2022.
  • The fiscal Q2 2026 figure represents the lowest quarterly Debt Ratio since fiscal Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 0.33
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 0.23
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 0.55
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 0.41
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn -0.06
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 0.56
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 0.51
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 0.31
10 Kazia Therapeutics 10.72 Mn -41.65 Mn - 0.20
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 0.20
Jun 30, 2025 0.59
Dec 31, 2024 0.15
Jun 30, 2024 0.33
Dec 31, 2023 0.32
Jun 30, 2023 0.37
Dec 31, 2022 0.02
Jun 30, 2022 0.05
Jun 30, 2018 0.00
Dec 31, 2014 0.58
Oct 3, 2014 0.06
Jun 30, 2014 0.58
Dec 31, 2013 0.25
Aug 30, 2013 0.25
Jun 30, 2013 0.25
API Access

Kazia Therapeutics Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=KZIA&period=max&api_key=YOUR_API_KEY